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INTRA-ARTICULAR HYALURONATE EFFICACY 
AND SAFETY IN TREATMENT OF KNEE OA 
t Moiler, C Moragues, N Marti, JJ Alegre 
/nstituto Poa/ de Reumato/ogia. Barce/ona 
Aim: The aim of this study was to assess the efficacy, the dur- 
ation of the efficacy and safety of intra-articular hyaluronate treat- 
ment in 40 patients with mild to moderate CA of the knee (2-3 
degree Keligren). 
Patients and Methods: Treatment was one intra-articular injec- 
tion of a 1% sodium hyaluronate in 2 ml buffer solution (OSTENIL) 
per week for 5 consecutive weeks; 40 patients (32 females and 8 
males, with a weight average of 64.4 kg and 56.8 year old mean) 
were followed for 6 months to assess efficacy, safety, and patient 
satisfaction, and was realized a wash out period for the CA treat- 
ment. An X-ray was taken at baseline. Periodic controls for the 
Lequesne index, pain (visual analogue scale), and subjective 
efficacy were carried out. 
Results: At baseline, 87.5% of the patients showed a total inca- 
pacity in one of the minimum daily life activities, assessed by 
Lequesne index. At the end of the study the efficacy variables, 
showed an absolute improvement i  97.5% of the patients. For all 
variables, the results were statistically significant in the evolution 
analysis for all visits (Friedman p<O.001 in all comparisons). Ninety 
five percent (95%) of the patients assessed treatment efficacy as 
very good or excellent, and the treatment showed a total safety 
during the study. 
Conclusions: These results show that the intra-articular treat- 
ment of knee CA process, with 5 intra-articular injections of 
OSTENIL is safe and effective, with significant improvements in 
all the studied indices (97.5%) and this improvement was main- 
tained until the end of the study period (6 months). 
Conclusion: Ultimately, the overriding benefit of this study was 
that effective CA pain/stiffness management may be achieved 
through methods other than those of potentially harmful drug 
regimens. 
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MEASUREMENT AND IMPACT OF THE ACETABULAR 
ANTEVERSION IN THE OSTEOARTHRITIS OF THE HIP 
S Terver, A Worcel, H Dechambre, J Y H~ry, G Poumarat, 
G Vanneuville 
C.H.U. Clermont-Ferrand France 
The anatomical factors may affect the evolution of osteoarthritis. 
We tested the signification of the orientation of the acetabulum in 
the appearance of the osteoarthritis of the hip. 
Methods: An original method of measurement of the anteversion 
of the acetabulum was developed by one of us. Its value was 
tested in normal and pathologic subjects by correlation intra 
observer and intra patients. We used it in 327 hips affected with 
osteoarthritis and 36 hips not affected but examined for other 
reasons. Were also measured the neck shaft angle and the 
femoral neck antetorsion using Dunlap method. 
Results: No correlation was found between neck orientation and 
osteoarthritis of the hip; on the other hand, a significant correla- 
tion was noted between acetabular anteversion and osteoarthri- 
tis of the hip at a 0.1% confidence level. The age at diagnosis 
was not found a significant factor. 
Conclusions: Anteversion of the acetabulum, if correctly meas- 
ured, appears as a significant factor in the pathogenesis of 
osteoarthritis of the hip. 
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EFFECT OF A TOPICAL HERBAL OINTMENT ON 
OSTEOARTHRITIS OF THE HAND AND KNEE: A 
RANDOMIZED CONTROLLED CLINICAL TRIAL 
HA Gemmell BH Jacobson, BM Hayes 
Oklahoma State University, Stillwater, Oklahoma and 
Intemational Research Consortium, Tulsa Oklahoma, USA 
Aim: The aim of this study was to compare the efficacy of an 
experimental osteoarthritis (CA) herbal-based, topical ointment 
(ARP TM) and a placebo ointment in the relief of osteroarthritic pain 
and stiffness of the hands and knees in patients diagnosed with 
CA. 
Methods: Subjects (N=30) were assigned to an experimental (EX) 
or a placebo (PL) group. For 42 consecutive days, applied the 
placebo or the experimental ointment to the affected site and 
recorded their level of pain and stiffness on visual analogue 
scales (VASs). Based on a previously study, data were separated 
into two categories: days 1 - 21 vs. days 22 - 42, and analyzed 
for between and within group differences. 
Results: The subjects characteristics were: mean age 60.4 yr. 
(SD= 11.6), height 65.54 in. (SD=3.2), and weight 172.5 Ib 
(SD=66.7). Significant differences in both pain (p=0.O03) and stiff- 
ness (p=0.0008) were found between the first 21 days and the last 
21 days of application for the EX group but not for the PL group. 
Analysis of gain scores between the EX and PL group yielded sig- 
nificant differences in both pain (p=0.026) and stiffness (p=0.042). 
No significant differences were found between gender for either 
pain or stiffness and no significant differences were found 
between hands and knees for pain or stiffness. 
PB25 
MODIFICATION OF OSTEOARTHRITIS BY 
ELECTROMAGNETIC FIELD EXPOSURE 
D. McK. Ciombor, R. K. Aaron, B. Simon 
Department of Orthopaedics, Brown Medica/ School 
Providence, R/, USA 
Hartley guinea pigs spontaneously develop arthritis that bears 
morphological, biochemical, and immunohistochemical similari- 
ties to osteoarthritis. It is characterized cartilage l sions by 12 
months of age and severe cartilage fibrillation and subsequent 
eburnation by 18 months of age. This study examines the effect 
of treatment with an electromagnetic field (EMF) upon the 
morphological progression of osteoarthritis in this animal model. 
Methods: Hartley guinea pigs were exposed to EMF for lh/day for 
6 months beginning at 12 months of age. Control animals were 
treated identically but without EMF exposure. Tibiat articular car- 
tilage was examined with histologicaVhistochemical grading of 
the severity of arthritis and by immunohistochemistry for cartilage 
neoepitopes 3B3(-) and BC-13, reflecting enzymatic leavage of 
aggrecan, and by immunoreactivity to collagenase (MMP 13) and 
stromelysin (MMP 3). Immunoreactivity o TGFJ~, IL-1, and IRAP 
antibodies was examined to suggest possible mechanisms of 
EMF activity. 
Results: EMF treatment preserved the integrity of articular carti- 
lage and retarded the development of osteoarthritic lesions. This 
observation was supported by a reduction in the cartilage neoepi- 
topes 3B3(-) and BC-13 and suppression of the matrix-degrading 
enzymes, collagenase and stromelysin. Cells immunopositive to 
IL-1 were decreased in number, while IRAP positive cells were 
